Literature DB >> 12195114

Diabetes, pulse pressure and cardiovascular mortality: the Hoorn Study.

Miranda T Schram1, Pieter J Kostense, Robert A Van Dijk, Jacqueline M Dekker, Giel Nijpels, Lex M Bouter, Robert J Heine, Coen D Stehouwer.   

Abstract

OBJECTIVE: Type 2 diabetic patients have an increased arterial stiffness and a very high risk of cardiovascular death. The present study investigated the relationship between pulse pressure, an indicator of vascular stiffness, and risk of cardiovascular mortality among type 2 diabetic and non-diabetic individuals. Second, we determined the relationship between pulse pressure and its main determinant (i.e. age), and the influence of diabetes and mean arterial pressure on this relationship. DESIGN AND METHODS: We studied a cohort of 2484 individuals including 208 type 2 diabetic patients. Mean age and median follow-up for non-diabetic and diabetic individuals, respectively, were 61 and 66 years, and 8.8 and 8.6 years. One-hundred and sixteen non-diabetic and 34 diabetic individuals died of cardiovascular causes. Relative risks of cardiovascular mortality were estimated by Cox proportional hazards regression adjusted for age, gender and mean arterial pressure.
RESULTS: Pulse pressure was associated with cardiovascular mortality among the diabetic, but not among the non-diabetic individuals [adjusted relative risk (95% confidence interval) per 10 mmHg increase, 1.27 (1.00-1.61) and 0.98 (0.85-1.13), P interaction = 0.07]. Further adjustment for other risk factors gave similar results. The association, at baseline, between age and pulse pressure was dependent on the presence of diabetes (P interaction = 0.03) and on the mean arterial pressure (P interaction< 0.001) (i.e. there was a stronger association when diabetes was present and when mean arterial pressure was higher).
CONCLUSIONS: We conclude that, in type 2 diabetes, pulse pressure is positively associated with cardiovascular mortality. The association between age and pulse pressure is influenced by the presence of type 2 diabetes and by the height of the mean arterial pressure. These findings support the concept of accelerated vascular aging in type 2 diabetes.

Entities:  

Mesh:

Year:  2002        PMID: 12195114     DOI: 10.1097/00004872-200209000-00017

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  47 in total

Review 1.  Systolic pressure, diastolic pressure, or pulse pressure as a cardiovascular risk factor in renal disease.

Authors:  José A García-Donaire; Luis M Ruilope
Journal:  Curr Hypertens Rep       Date:  2010-08       Impact factor: 5.369

Review 2.  Mechanisms, significance and treatment of vascular dysfunction in type 2 diabetes mellitus: focus on lipid-regulating therapy.

Authors:  Richard J Woodman; Gerard T Chew; Gerald F Watts
Journal:  Drugs       Date:  2005       Impact factor: 9.546

Review 3.  Arterial stiffness in diabetes and the metabolic syndrome: a pathway to cardiovascular disease.

Authors:  C D A Stehouwer; R M A Henry; I Ferreira
Journal:  Diabetologia       Date:  2008-02-01       Impact factor: 10.122

4.  Ambulatory pulse pressure, decreased nocturnal blood pressure reduction and progression of nephropathy in type 2 diabetic patients.

Authors:  S T Knudsen; E Laugesen; K W Hansen; T Bek; C E Mogensen; P L Poulsen
Journal:  Diabetologia       Date:  2009-01-29       Impact factor: 10.122

5.  Sexual Dimorphism in Obesity-Associated Endothelial ENaC Activity and Stiffening in Mice.

Authors:  Jaume Padilla; Makenzie L Woodford; Guido Lastra-Gonzalez; Vanesa Martinez-Diaz; Shumpei Fujie; Yan Yang; Alexandre M C Lising; Francisco I Ramirez-Perez; Annayya R Aroor; Mariana Morales-Quinones; Thaysa Ghiarone; Adam Whaley-Connell; Luis A Martinez-Lemus; Michael A Hill; Camila Manrique-Acevedo
Journal:  Endocrinology       Date:  2019-12-01       Impact factor: 4.736

6.  Increased arterial augmentation and augmentation index as surrogate parameters for arteriosclerosis in subjects with diabetes mellitus and nondiabetic subjects with cardiovascular disease.

Authors:  Birgit Wilhelm; Johannes Klein; Christiane Friedrich; Senait Forst; Andreas Pfützner; Peter H Kann; Matthias M Weber; Thomas Forst
Journal:  J Diabetes Sci Technol       Date:  2007-03

7.  The Maastricht Study: an extensive phenotyping study on determinants of type 2 diabetes, its complications and its comorbidities.

Authors:  Miranda T Schram; Simone J S Sep; Carla J van der Kallen; Pieter C Dagnelie; Annemarie Koster; Nicolaas Schaper; Ronald M A Henry; Coen D A Stehouwer
Journal:  Eur J Epidemiol       Date:  2014-04-23       Impact factor: 8.082

Review 8.  The J-curve in hypertension.

Authors:  John Cruickshank
Journal:  Curr Cardiol Rep       Date:  2003-11       Impact factor: 2.931

9.  Pulsatile stress in middle-aged patients with type 1 or type 2 diabetes compared with nondiabetic control subjects.

Authors:  Jean-Christophe Philips; Monique Marchand; André J Scheen
Journal:  Diabetes Care       Date:  2010-08-06       Impact factor: 17.152

10.  Location of arterial stiffening differs in those with impaired fasting glucose versus diabetes: implications for left ventricular hypertrophy from the Multi-Ethnic Study of Atherosclerosis.

Authors:  Pairoj Rerkpattanapipat; Ralph B D'Agostino; Kerry M Link; Eyal Shahar; Joao A Lima; David A Bluemke; Shantanu Sinha; David M Herrington; W Gregory Hundley
Journal:  Diabetes       Date:  2009-01-09       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.